U.S. Markets close in 5 hrs, 50 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,511.31 | -121.07 | -1.04% |
| NASDAQ | 2,307.08 | -18.80 | -0.81% |
| S&P 500 | 1,273.28 | -8.91 | -0.69% |
| Day Low 09:35 AM EDT | 27.16 | |
|---|---|---|
| Day High 09:30 AM EDT | 28.06 |
|
| Range | 0.90 | |
| Volume | 86,468 | |
| 30-Day Avg. Vol. | 786,000 |
|
| Difference | -89.00% | |
| Market Cap. | 1.56 B | |
| Change | -18.21 M | |
| Shares Out. | 56.92 M | |
| Percent Traded | 0.15% | |
| Revenue | 129.47 M | |
| Earnings | -21.42 M | |
| EPS (TTM) | -0.32 |
| 52-Wk Low 7/26/07 | 14.27 | |
|---|---|---|
| 52-Wk High 1/24/08 | 33.36 |
|
| Range | 19.09 | |
| Prev. Close 7/23/08 | 27.86 | |
| Today's Open | 27.97 | |
| Change | 0.39% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.6999 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -16.00 |
Cepheid sees DNA faster. The molecular diagnostics firm develops systems that automate the process of preparing and amplifying DNA in order to quickly detect diseases and harmful agents. Its two instrument ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.08 12/31/07 | -0.095 12/31/07 |
-0.015
Missed
|
| Last Quarter | -0.08 3/31/08 | -0.03 3/31/08 |
0.05
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 44.83 M | 129.47 M |
| Gross Profit | 21.85 M | 60.30 M |
| Operating Income | -3.47 M | -24.49 M |
| Net Income | -1.85 M | -21.42 M |
Real-Time Quote
